Clinical trial
An Open -Label Study to Evaluate the Effect of Pandel Cream 0.1% on the Hypothalamic Pituitary Adrenal Axis in the Pediatric and Adult Population
NCT01137032 is registered in ClinicalTrials.gov with Fougera Pharmaceuticals Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open -Label Study to Evaluate the Effect of Pandel Cream 0.1% on the Hypothalamic Pituitary Adrenal Axis in the Pediatric and Adult Population
- Lead sponsor
- Fougera Pharmaceuticals Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2004
- Completion date
- August 31, 2005
- Enrollment
- 19 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis, psoriasis